A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

NCT06602479 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

488

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: MEDI0618
DRUG: Placebo

Sponsor

AbbVie